Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06684990

Point-of-Care Testing in Outpatient Diabetes Care

Evaluation of a Fast Point-of-care Platform for Diabetes Care at Out-patient Clinics

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
222 (actual)
Sponsor
Taichung Veterans General Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Using a point-of-care (POC) platform, the investigators will investigate the effects of POC testing for glycated hemoglobin (HbA1c) and cystatin C at out-patient clinics on long-term diabetes outcomes.

Detailed description

Laboratory testing for HbA1c and cystatin C is time-consuming, and healthcare providers often do not have update results when they evaluate outpatients with diabetes. A POC testing platform may help address this issue, and the investigators aim to examine its effects on diabetes outcomes.

Conditions

Interventions

TypeNameDescription
OTHERPOC testingPOC testing for HbA1c and cystatin C

Timeline

Start date
2025-01-02
Primary completion
2028-04-01
Completion
2028-04-01
First posted
2024-11-12
Last updated
2025-09-11

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06684990. Inclusion in this directory is not an endorsement.

Point-of-Care Testing in Outpatient Diabetes Care (NCT06684990) · Clinical Trials Directory